Predictors of renal involvement in patients with systemic lupus erythematosus

Asian Pacific Journal of Allergy and Immunology

Volumn 25, Issue 1, 2007, Pages 17-25

  Satirapoj, Bancha ^a   Wongchinsri, Jeerapat ^a   Youngprang, Nantana ^a   Laonapaporn, Boonraksa ^a   Thongdee, Chitrada ^a   Lapkittichareonchai, Sumonkarn ^a   Patumanond, Jayanton ^b  

^a Nopparat Rajathanee Hospital   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; CREATININE; DOUBLE STRANDED DNA ANTIBODY; HEMOGLOBIN; NITROGEN; UREA;

ADULT; ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHOTOSENSITIVITY; PREDICTION; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; UREA NITROGEN BLOOD LEVEL; VASCULITIS;

ADULT; ANTIBODIES, ANTINUCLEAR; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 34250890675     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GR. Systemic lupus erythematosus. Lancet 2001; 357: 1027-32.
2. Donadio JV Jr, Hart GM, Bergstralh EJ, Holley KE. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus 1995; 4: 109-15.
3. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996; 156: 1337-44.
4. Vu TV, Escalante A. A comparison of the quality of life of patients with systemic lupus erythematosus with and without end stage renal disease. J Rheumatol 1999; 26: 2595-601.
5. Wallace DH, Hahn BH. Dubois' lupus erythematosus, 4th edition. Baltimore: Lea & Febiger; 1993.
6. Petri M. Hopkins Lupus Cohort. 1999 update. Rheum Dis Clin North Am 2000; 26: 199-213.
7. Lee SS, Li CS, Li PC. Clinical profile of Chinese patients with systemic lupus erythematosus. Lupus 1993; 2: 105-9.
8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-70.
10. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-50.
11. Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ. Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group. Kidney Int 1992; 42: 743-8.
12. Boumpas DT, Balow JE. Outcome criteria for lupus nephritis trials: a critical overview. Lupus 1998; 7: 622-9.
13. Dang H, Harbeck RJ. The in vivo and in vitro glomerular deposition of isolated anti-double-stranded-DNA antibodies in NZB/W mice. Clin Immunol Immunopathol 1984; 30: 265-78.
14. Koffler D, Schur PH, Kunkel HG. Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 1967; 126: 607-23.
15. Vargas MT, Gustilo K, D'Andrea DM, Kalluri R, Foster MH, Madaio MP. Structural features of nephritogenic lupus autoantibodies. Methods 1997; 11: 62-9.
16. Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 1994; 45 544-50.
17. Wallace DJ, Podell TE, Weiner JM, Cox MB, Klinenberg JR, Forouzesh S, et al. Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980. Am J Med 1982; 72: 209-20.
18. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2002; 16: 847-58.
19. Nossent HC, Henzen-Logmans SC, Vroom TM, Berden JH, Swaak TJ. Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. Arthritis Rheum 1990; 33: 970-7.
20. Edwards CJ. Lupus in Singapore. Lupus 2001; 10: 889-91.
21. Mok CC, Lau CS. Lupus in Hong Kong Chinese. Lupu 2003; 12: 717-22.
22. Huong DL, Papo T, Beaufils H, Wechsler B, Bletry O, Baumelou A, et al. Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine (Baltimore) 1999; 78: 148-66.
23. Martins L, Rocha G, Rodrigues A, Santos J, Vasconcelos C, Correia J, et al. Lupus nephritis: a retrospective review of 78 cases from a single center. Clin Nephrol 2002; 57: 114-9.
24. Bono L, Cameron JS, Hicks JA. The very long-term prognosis and complications of lupus nephritis and its treatment. QJM 1999; 92: 211-8.
25. Kasitanon N, Louthrenoo W, Sukitawut W, Vichainun R. Causes of death and prognostic factors in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 2002; 20: 85-91.
26. Sbayakul C, Ong-aj-yooth L, Chirawong P, Nimmannit S, Parichatikanond P, Laohapand T, et al. Lupus nephritis in Thailand: clinicopathologic finding and outcome in 569 patients. Am J Kidney Dis 1995; 26: 300-7.
27. Alba P, Bento L, Cuadrado MJ, Karim Y, Tungekar MF, Abbs I, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 2003; 62: 556-60.
28. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, et al. Fc gamma, RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 1996; 97: 1348-54.